Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Repeat hepatectomy for recurrent hepatocellular carcinoma

N Nagasue1, H Kohno, T Hayashi

  • 1Second Department of Surgery, Shimane Medical University, Izumo, Japan.

The British Journal of Surgery
|January 1, 1996
PubMed
Summary

Repeat hepatectomy can be a viable option for recurrent hepatocellular carcinoma (HCC). This approach offers improved survival rates, particularly for patients with solitary tumors and good liver function (Child grade A).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective approaches to gastric cancer patients with liver metastases: role of liver-directed chemotherapy.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2002
Same author

Repeated hepatic dearterialization for unresectable carcinomas of the liver: report of a 10-year experience.

Surgery today·2002
Same author

Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in rats.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Same author

Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver.

Journal of hepatology·2001
Same author

Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials.

Cancer·2001
Same author

The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Hepatocellular Carcinoma Research

Background:

  • Hepatocellular carcinoma (HCC) frequently recurs after initial treatment.
  • Repeat hepatectomy is a potential salvage treatment for intrahepatic recurrence.
  • Understanding outcomes and limitations of repeat hepatectomy is crucial.

Purpose of the Study:

  • To evaluate the outcomes of repeat hepatectomy for recurrent HCC.
  • To identify patient selection criteria and limitations of repeat hepatectomy.

Main Methods:

  • Retrospective analysis of 290 patients with initial radical hepatic resection for HCC.
  • Focus on 50 patients who underwent repeat hepatectomy for intrahepatic recurrence.
  • Comparison of outcomes between repeat hepatectomy and other treatments for recurrence.

Related Experiment Videos

Main Results:

  • Fifty patients underwent repeat hepatectomy for recurrent HCC.
  • Operative mortality for repeat hepatectomy was 8% (second) and 16.7% (third), compared to 4.5% for initial hepatectomy.
  • Five-year survival was 41% for repeat hepatectomy patients versus 7% for others; survival was better in Child grade A patients.

Conclusions:

  • Repeat hepatectomy can be beneficial for selected patients with recurrent HCC.
  • Ideal candidates have solitary recurrence and Child grade A liver function.
  • Careful patient selection is essential to mitigate risks associated with repeat liver surgery.